A multicenter, randomized, parallel-group, trial to reduce toxicity of calcineurininhibitor-therapy [ciclosporin] in steroid-free longterm immunosuppression in pediatric and adolescent kidney transplant recipients.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ciclosporin (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms Recaltox
Most Recent Events
- 04 Jun 2015 Biomarkers information updated
- 28 Apr 2012 New source identified and integrated (European Clinical Trials Database).
- 09 Nov 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.